MICAL-L2 has been shown to be significantly upregulated in ovarian cancer tissues in a FIGO stage-dependent manner and has also been associated with histologic subgroups of ovarian cancer [11]. This evidence concerns the gene MICALL2 and ovarian carcinoma.